Acta Pharmaceuticals raised $24 million in seed funding.
- Amount
- $24M
- Stage
- Seed
- Announced
- 15 October 2026
- Investors
- Alzheimer's Disease Research Foundation, Dolby Family Ventures, Gamma Bio Investors
- Use of funds
- Advance lead clinical candidate GSM-779690T into clinical evaluation and other therapeutic candidates.
- Checked
- Amount and date checked against the press source